What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News Pulseras Candela promotes research on pediatric ependymoma in Vall d'Hebron The association makes the fifth annual donation of 52,390€ that will finance a project to study new therapies for this childhood tumor. News Vall d’Hebron participates in a European project against obstetric violence The team will design and implement a training program for professionals for the respectful care of maternity and childbirth. News A trial run by Vall d'Hebron demonstrates, for the first time, the effectiveness of involving consulates in health campaigns aimed at immigrant communities The initiative, carried out at the Consulate of Bolivia, has resulted in 307 new tests for the diagnosis of Chagas disease News Vall d'Hebron, the UPC and Probitas create iMAGING, an app that uses artificial intelligence to diagnose malaria The new diagnostic method, designed for use in endemic regions, combines a mobile application with a low-cost robotic microscope. News Vall d'Hebron highlights the importance of organoids in research and personalized medicine On January 24, a session was held to explain what these three-dimensional models are and what advantages they have, as well as to review some of their applications in research. Activities Jornada 'Organoides al servei de la recerca: aplicacions, avanços i reptes' PROGRAMA 10:00h Benvinguda Begoña Benito, directora de la Vall d'Hebron Institut de Recerca (VHIR) 10:10h Què són els organoides? Quines són les seves aplicacions? Shirle Activities Jornada 'Organoides al servicio de la investigación: aplicaciones, avances y retos' PROGRAMA 10:00h Bienvenida Begoña Benito, directora del Vall d’Hebron Institut de Recerca (VHIR) 10:10h ¿Qué son los organoides?, ¿Cuáles son sus aplicaciones? Shirley Guzmán Avilés Gestora de News Vall d'Hebron receives 2.6 million euros for research into advanced therapies CERTERA's objective is to create a coordinated research and innovation structure to accelerate the preclinical and early stage clinical development of these types of therapies. News The Ministry of Science and Innovation awards €4 million for the Phase 2b clinical trial with a new drug for ischemic stroke Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients. Activities PhD Training Programme 2024 i formació de gener En el marc de la HRS4R, i com una de les accions relacionades amb la formació i el desenvolupament professional, us presentem la programació del PhD Training Programme 2024. Aquest programa ha estat organitzat de forma conjunta per la Unitat d Activities Vall d'Hebron Talks 'Dona i VIH' Ponent: Dra. Paula Suanzes Díez, metgessa adjunta en el servei de Malalties Infeccioses des del 2019. Em dedico particularment al camp de la infecció per VIH i també treballo a l'àrea d'hospitalització i investigadora predoctoral del grup de recerca de Malalties infeccioses. Vall Hebron Institut News The pre-enrollment for the 11th edition of Translational Biomedical Research Master at VHIR is now open More than 400 students interested in acquiring knowledge and skills that will allow them to dedicate themselves to research aimed at finding solutions to people's health problems have already passed through the Master. Activities Inauguració de l'exposició 'Ultrasons, de la natura a la medicina' News Combination of antitumor drugs improves survival in patients with an aggressive type of pediatric cancer The BEACON clinical trial, in which Vall d'Hebron participates, has observed that adding Bevacizumab to treatment with different chemotherapy drugs reduces tumor size in a greater number of patients. News The Fortalece - Health program awards 2.4 million euros to Vall d'Hebron to promote research in chronic and minority diseases In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies. News VHIR participates in a European project to optimise AI and data analytics use in healthcare Phase IV AI is included in the Horizon Europe programme, lasts 3 years and prioritises data security and privacy compliance. News Work Led by Vall d'Hebron recognized in Third Edition of Esperanza Nacional Award for Research in Multiple Sclerosi Dr. Carmen Espejo and Dr. Georgina Arrambide, researchers at Cemcat and Vall d'Hebron Research Institute, are the first authors of the article. Activities Retiment de Comptes de l'Hospital Universitari de Vall d'Hebron Vine al retiment de comptes de l'Hospital el pròxim 21 de desembre El pròxim dijous 21 de desembre, a les 13.00 hores Activities Vall d'Hebron Talks 'Sumant anys amb el VIH. Què hem de tenir en compte?' Ponent: Dr. Jordi Navarro Mercadé, metge especialista en Medicina Interna de l'Hospital Universitari Vall d'Hebron amb activitat centrada exclusivament a l'àrea de Malalties Infeccioses. La seva formació s'ha focalitzat a l'atenció a les persones amb VIH. Les seves àrees d'interès són la co News Interaction between the microbiota and the immune system influences the development of type 1 diabetes These are the results of a study published in Nature Communications and led by the Vall d'Hebron Research Institute (VHIR), the University of Lleida (UdL) and the Biomedical Research Institute of Lleida (IRBLleida). Pagination First page « Previous page ‹ … Page 15 Page 16 Current page 17 Page 18 Page 19 … Next page › Last page »
